In addition to improvement of insulin resistance, DPP4 inhibitor ameliorated visceral adiposity via inhibition of adipogenesis by partial enhancement of energy expenditure along with metabolic changes in DIO-mice [48]. The gene discussed is DPP4; the disease is Insulin resistance.